HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Research breakthroughs prompt ‘renaissance’ of collaboration between oncologists, HIV experts
-
- Maximizing durable remissions in malignant melanoma: The next steps Michael K. Wong, MD, PhD
- Jacob, Bertino made HemOnc Today a leader in hematology, oncology
- Surgeon General report identifies more health hazards from smoking
- Electronic directly observed therapy benefited children with sickle cell disease
- Increased use of breast reconstruction after mastectomy varied geographically
- Cervical cancer screening overused in women at low risk
- Crizotinib beyond progressive disease improved survival in ALK-positive NSCLC
- Enzalutamide improved outcomes in prostate cancer regardless of age
-
- Intraoperative heparin demonstrated low risk for recurrent HIT
- Previous CIN3 diagnosis doubled cervical, vaginal cancer mortality risk
- Subcutaneous rituximab noninferior to IV formulation in follicular lymphoma
- HPV-positive OPSCC patients showed longer time to onset of distant metastases
- Mutant-allele tumor heterogeneity, HPV status predicted HNSCC outcomes
- Contralateral submandibular gland-sparing radiation safe, effective in head, neck cancers
- Reduced radiation minimized xerostomia in oropharyngeal cancer